Format

Send to

Choose Destination
Clin Microbiol Infect. 2018 Apr;24(4):328-331. doi: 10.1016/j.cmi.2018.01.001. Epub 2018 Jan 8.

Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C?

Author information

1
National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy. Electronic address: giuseppe.ippolito@inmi.it.
2
Division of Infection and Immunity, University College London, NIHR Biomedical Research Centre at UCL Hospitals NHS Foundation Trust, London, United Kingdom.
3
National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.

KEYWORDS:

Direct-acting antivirals for chronic hepatitis C; Evidence-based medicine; Hepatitis C; Hepatocellular carcinoma; Meta-analysis; Observational study; Outcome research; Randomized controlled study; Sustained virologic response

PMID:
29326009
DOI:
10.1016/j.cmi.2018.01.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center